FR2414914A1 - Utilisations therapeutiques nouvelles de l'acetyl-1-carnitine et d'autres derives acyles de la 1-carnitine - Google Patents

Utilisations therapeutiques nouvelles de l'acetyl-1-carnitine et d'autres derives acyles de la 1-carnitine

Info

Publication number
FR2414914A1
FR2414914A1 FR7832407A FR7832407A FR2414914A1 FR 2414914 A1 FR2414914 A1 FR 2414914A1 FR 7832407 A FR7832407 A FR 7832407A FR 7832407 A FR7832407 A FR 7832407A FR 2414914 A1 FR2414914 A1 FR 2414914A1
Authority
FR
France
Prior art keywords
carnitine
derivs
ischaemia
acylated
useful
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7832407A
Other languages
English (en)
Other versions
FR2414914B1 (fr
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sigma Tau Industrie Farmaceutiche Riunite SpA
Original Assignee
Sigma Tau Industrie Farmaceutiche Riunite SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from IT4767678A external-priority patent/IT1155772B/it
Priority claimed from IT4789978A external-priority patent/IT1155814B/it
Application filed by Sigma Tau Industrie Farmaceutiche Riunite SpA filed Critical Sigma Tau Industrie Farmaceutiche Riunite SpA
Publication of FR2414914A1 publication Critical patent/FR2414914A1/fr
Application granted granted Critical
Publication of FR2414914B1 publication Critical patent/FR2414914B1/fr
Granted legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/23—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms

Landscapes

  • Health & Medical Sciences (AREA)
  • Emergency Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

a. L'invention concerne un procédé nouveau pour la thérapie cardiaque. b. Ce procédé est caractérisé en ce qu'on utilise, comme produit actif, l'acétyl-1-carnitine et d'autres dérivés de la 1-carnitine ainsi que leurs sels admissibles comme produits pharmaceutiques. c. Ces nouveaux médicaments font preuve d'une bonne activité pour la thérapie de l'anoxie du muscle cardiaque, de l'ischémie, des insuffisances cardiaques et autres.
FR7832407A 1978-01-18 1978-11-16 Utilisations therapeutiques nouvelles de l'acetyl-1-carnitine et d'autres derives acyles de la 1-carnitine Granted FR2414914A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT4767678A IT1155772B (it) 1978-01-18 1978-01-18 Applicazione terapeutica del l'acetil-i-carnitina e di altri derivati acilati della i-carnitina
IT4789978A IT1155814B (it) 1978-02-03 1978-02-03 Nouva applicazione terapeutica dell'acetil-i-carnitina e di altri derivati acilati della i-carnitina

Publications (2)

Publication Number Publication Date
FR2414914A1 true FR2414914A1 (fr) 1979-08-17
FR2414914B1 FR2414914B1 (fr) 1983-04-15

Family

ID=26329217

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7832407A Granted FR2414914A1 (fr) 1978-01-18 1978-11-16 Utilisations therapeutiques nouvelles de l'acetyl-1-carnitine et d'autres derives acyles de la 1-carnitine

Country Status (1)

Country Link
FR (1) FR2414914A1 (fr)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2425855A1 (fr) * 1978-05-15 1979-12-14 Cavazza Claudio Application des acyl-carnitines a un procede therapeutique de traitement de patients uremiques chroniques en traitement hemodialytique periodique et composition liquide de dialyse pour la mise en oeuvre d'un tel procede
FR2448348A1 (fr) * 1979-02-12 1980-09-05 Cavazza Claudio Composition pharmaceutique comprenant une acyl-carnitine pour le traitement du metabolisme cerebral perturbe
FR2448347A1 (fr) * 1979-02-12 1980-09-05 Cavazza Claudio Composition pharmaceutique comprenant une acyl-carnitine pour le traitement des maladies vasculaires peripheriques
FR2482588A1 (fr) * 1980-05-15 1981-11-20 Sigma Tau Ind Farmaceuti Composition pharmaceutique pour le traitement du diabete sucre juvenile

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1573430A (fr) * 1967-07-03 1969-07-04
JPS4980272A (fr) * 1972-12-08 1974-08-02
DE2817358A1 (de) * 1977-04-29 1978-11-02 Sigma Tau Ind Farmaceuti Neue therapeutische anwendung von acylderivaten des d,l-carnitin

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1573430A (fr) * 1967-07-03 1969-07-04
JPS4980272A (fr) * 1972-12-08 1974-08-02
DE2817358A1 (de) * 1977-04-29 1978-11-02 Sigma Tau Ind Farmaceuti Neue therapeutische anwendung von acylderivaten des d,l-carnitin
FR2388556A1 (fr) * 1977-04-29 1978-11-24 Sigma Tau Ind Farmaceuti Application therapeutique de l'acetyl-carnitine-d,1 et d'autres derives acyliques de la carnitine-d,1

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
CA1975 *

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2425855A1 (fr) * 1978-05-15 1979-12-14 Cavazza Claudio Application des acyl-carnitines a un procede therapeutique de traitement de patients uremiques chroniques en traitement hemodialytique periodique et composition liquide de dialyse pour la mise en oeuvre d'un tel procede
FR2448348A1 (fr) * 1979-02-12 1980-09-05 Cavazza Claudio Composition pharmaceutique comprenant une acyl-carnitine pour le traitement du metabolisme cerebral perturbe
FR2448347A1 (fr) * 1979-02-12 1980-09-05 Cavazza Claudio Composition pharmaceutique comprenant une acyl-carnitine pour le traitement des maladies vasculaires peripheriques
FR2482588A1 (fr) * 1980-05-15 1981-11-20 Sigma Tau Ind Farmaceuti Composition pharmaceutique pour le traitement du diabete sucre juvenile

Also Published As

Publication number Publication date
FR2414914B1 (fr) 1983-04-15

Similar Documents

Publication Publication Date Title
FR2388556A1 (fr) Application therapeutique de l'acetyl-carnitine-d,1 et d'autres derives acyliques de la carnitine-d,1
KR890009967A (ko) 아데노신 유도체
DE2414680C2 (de) Substituierte 2-Furancarbonsäuren und 2-Furancarbonsäureester, Verfahren zu ihrer Herstellung und Arzneimittel, die diese Verbindungen enthalten
KR840003414A (ko) 3-히드록시부탄산 또는 이 산으로부터 유도된 염을 함유하는 약학적 조성물과, 의약품으로 사용할 수 있는 3-히드록시부탄산으로부터 유도된 화합물
FR2414914A1 (fr) Utilisations therapeutiques nouvelles de l'acetyl-1-carnitine et d'autres derives acyles de la 1-carnitine
EA018127B1 (ru) Применение производных глутаровой кислоты или их фармацевтически приемлемых солей в качестве противоаритмических средств
KR950000141A (ko) 피부병 치료용 약제조성물 제조를 위한 방향족산을 함유한 l- 카르니틴 o-에스테르의 용도
DE2311131C3 (de) Amidinopenicillansäureester, Verfahren zu deren Herstellung und pharmazeutische Mittel
WO1993019742A1 (fr) Medicament visant a remedier aux maladies cardiovasculaires
US6548693B2 (en) Nitriloxy derivatives of (R) and (S)-carnitine
US3697563A (en) (3,4,5-trimethoxy-benzamido)-alkanoic acids for prophylaxis and treatment of cardiac disorders
IL37139A (en) Trialkoxybenzoyl aminoalkanoic acid derivatives and pharmaceutical compositions containing them
US3769335A (en) Derivatives of aminoalkanoic acids
KR930023338A (ko) 데포우 제제
DE2148986C3 (de) Salze der Chondroitinschwefelsäure mit Carboxymethyl-trhnethylammoniumhydroxid, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel
US3104203A (en) Composition of matter containing procaine adenylate
US3726913A (en) Derivatives of aminoalkanoic acids
FR2373522A1 (fr) Nouveaux esters d'acides benzenesulfoniques substitues, leur procede de preparation et medicament les contenant
US3692827A (en) Derivatives of aminoalkanoic acids
US3857949A (en) Prophylaxis and treatment of cardiac disorders
US3803222A (en) Oxo-trialkoxyphenyl-alkanoic acids and salts thereof
Campbell et al. Nifedipine in the treatment of life threatening Prinzmetal angina
JPH07121863B2 (ja) 脳虚血性病変を伴う疾患治療剤
KR100263085B1 (ko) 신규의 알카로이드 유도체, 이의 용도 및 이를 함유한 제약적 조성물
US3789070A (en) Prophylaxis and treatment of cardiac 3,4,5-trialkoxyphenylalkanoic acids and salts thereof